President Joe Biden said Monday that the U.S. will share an additional 20 million doses of COVID-19 vaccines with the world in the coming six weeks as domestic demand for shots drops and global disparities in distribution have grown more evident.
The doses will come from existing production of Pfizer, Moderna or Johnson & Johnson vaccine stocks, marking the first time that U.S.-controlled doses of vaccines authorized for use in the country will be shared overseas. It will boost the global vaccine sharing commitment from the U.S. to 80 million.
“We know America will never be fully safe until the pandemic that’s raging globally is under control," Biden said at the White House.
The announcement comes on top of the Biden's administration’s prior commitment to share about 60 million doses of the AstraZeneca vaccine, which is not yet authorized for use in the U.S., by the end of June. The AstraZeneca doses will be available to ship once they clear a safety review by the Food and Drug Administration.
Biden also tapped COVID-19 coordinator Jeff Zients to lead the administration's efforts to share doses with the world.
“Our nation’s going to be the arsenal of vaccines for the rest of the world," Biden said. He added that, compared to other countries like Russia and China that have sought to leverage their domestically produced doses, “we will not use our vaccines to secure favors from other countries.”
The Biden administration hasn't yet said how the new commitment of vaccines will be shared or which countries will receive them.
To date, the U.S. has shared about 4.5 million doses of AstraZeneca vaccine with Canada and Mexico. Additional doses of the Pfizer vaccine manufactured in the U.S. have begun to be exported as the company has met its initial contract commitments to the federal government.
The U.S. has faced growing pressure to share more of its vaccine stockpile with the world as interest in vaccines has waned domestically.
“While wealthy countries continue ramping up vaccinations, less than 1 percent of COVID-19 vaccine doses globally have been administered to people in low-income countries," said Tom Hart the acting CEO of the ONE Campaign. “The sooner the US and other wealthy countries develop a coordinated strategy for sharing vaccine doses with the world’s most vulnerable, the faster we will end the global pandemic for all.”
More than 157 million Americans have received at least one dose of a COVID-19 vaccine, and 123 million are full vaccinated against the virus. Biden hopes the U.S. will have 160 million people fully vaccinated by July Fourth.
Globally, more than 3.3 million people are confirmed to have died from the coronavirus. The U.S. has seen the largest confirmed loss of life from COVID-19, at more than 586,000 people.
Ayman Mohyeldin, host of MSNBC Original Podcast 'American Radical,' joins Cheddar News to discuss how the podcast chronicles a woman's path to the insurrection.
Following the attack on the Capitol last year, several major corporations promised to no longer pour funds into the campaigns of Republican lawmakers who supported the January 6 insurrection. But not all have stood firm on their word. Among those that did keep to their promise were Nike, American Express, and Walgreens.
Rep. Annie Kuster (D-N.H. 2nd District) joined Cheddar's "Between Bells" to reflect on the January 6 insurrection and her personal experience in the Capitol when rioters attempted to overtake the House chamber. "What I now understand to be true is that the mob of rioters had reached the third floor and was literally in the hallway running toward us as we ducked into the elevator," she told Cheddar. Kuster recalled the fear she felt, wondering what might have happened if the insurrectionists crossed paths with her group. Kuster noted that she has since received therapy to help cope with the traumatic event. "A thousand acts of courage saved our life and saved our democracy," she said.
Andy Kroll, Washington bureau chief at Rolling Stone, joined Cheddar's Baker Machado to discuss the anniversary of the January 6 insurrection and how it could impact upcoming elections. Kroll talked about whether or not Trump's influence will aid Republicans in the midterms and how it could be a setup for the former president to run in the 2024 presidential election. "This day has become really almost a kind of cause for Republican base voters," he said. "And you're going to see that fueling some turnout, you're going to see that fueling, even, candidates running for office in these midterm elections."
According to a recent analysis from ProPublica and the Wall Street Journal an analysis of Facebook posts, internal company documents, and interviews reveal key evidence about the social media giant's role in January 6 insurrection. National Reporter at ProPublica Craig Silverman, joined Cheddar to discuss more.
AT&T and Verizon have agreed to delay activating their 5G services for two weeks after Airlines for America, a lobbying group that represents American, Delta, and other airlines, filed a petition last week with the FCC to stop the deployment of 5G in the U.S. over concerns that the network can interfere with certain systems on airplanes. President Biden spoke out about it, saying it would avoid further delays and cancellations of flights. Light Reading 5G and Mobile Strategies Director Mike Dano joined Cheddar News' Closing Bell to discuss.
On a day where the Dow and Russell 2000 each closed more than 3% lower, Melissa Armo, founder and owner of The Stock Swoosh, says Wednesday's big sell-off could extend into after-hours trading. She joined Cheddar News' Closing Bell for more.
The new year has just gotten underway, but the clock is already ticking for the Democratic-led Congress to pass bills regulating big tech. Evan Greer, Director for Fight For the Future, joins Cheddar News to explain why Democratic lawmakers would want to push legislation now, and what a Republican takeover would mean for the industry.
Americans looking to purchase at-home COVID-19 tests will now have to shell out a bit more money after an agreement expired between the White House and companies to sell the tests at cost. The price of Abbot's BinaxNow test kit from October to December was $14 apiece; on Tuesday, Walmart's website listed the test for $19.88, and Kroger listed the tests for $23.99. Carbon Health Regional Clinical Director Dr. Bayo Curry-Winchell joined Cheddar News' Closing Bell to discuss the impact higher prices will have as the nation experiences another surge in cases.
